# OnCo record nct04606446 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct04606446/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct04606446", "NCT04606446" ;
  schema:name "Study of PF-07248144 in Advanced or Metastatic Solid Tumors"@en ;
  schema:description "A phase 2 trial of PF-07248144, Fulvestrant, Letrozole in prostate cancer and non-small-cell lung cancer, run by Pfizer, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct04606446/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04606446> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "2" ;
  schema:startDate "2020-11-16" ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/sclc/> ;
  onco:drugs <https://onco.cc/drugs/pf-07248144/>, <https://onco.cc/drugs/fulvestrant/>, <https://onco.cc/drugs/letrozole/>, <https://onco.cc/drugs/palbociclib/>, <https://onco.cc/drugs/atirmociclib/>, <https://onco.cc/drugs/vepdegestrant/> ;
  onco:companies <https://onco.cc/companies/pfizer/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-nct04606446-nat-med-2024/> .